IMPACT! NEWSLETTER: JANUARY 2018

Footer Background_v2 copy

We are pleased to introduce our quarterly e-Newsletter – IMPACT! The name reflects our company’s values and intent of sharing the latest trends and topics impacting the health ecosystem.

For more information on how we partner with our clients to develop leaders to execute strategy, visit our Coaching Solutions page. Please send any comments and feedback to info@tldgroupinc.com.

 

HEALTH ECOSYSTEM HIGHLIGHTS

Cross-sector collaboration guides much of our work and that of our clients. We are pleased to share recent success stories from across the health ecosystem. These examples demonstrate the innovative thinking and practical application of health ecosystem leadership and its impact on health outcomes.

Payer, provider collaboration required for accountable care success
Health Payer Intelligence

Payer-provider accountable care collaborations has the potential to achieve high-quality clinical outcomes by combining payers’ data analytics capabilities with providers’ healthcare delivery expertise. Examples of successful ACO collaborative agreements include that between UnitedHealthcare and Phoenix Children’s, and between Cigna and Catalyst Health.

Penn State Health, Highmark Health sign $1B value-based care network deal
Fierce Healthcare

Penn State Health and Highmark, one of the nation’s top health insurers, have entered into a joint venture partnership through the creation of a value-based care network deal to improve population health. This collaboration will include new facilities and cobranded health insurance products.

Unique payer-provider cancer treatment partnerships
Managed Healthcare Executive

In an effort to address the high cost and fragmented nature of cancer care, Cigna partners with oncology practices in value-based program to improve care coordination. This program provides practices with funding, thereby allowing them to provide round-the-clock care and hire nonclinical team members such as nurse care managers, dieticians, and nutritionists.

Carmot, Amgen form drug discovery partnership
Pharmaceutical Business Review

Carmot Therapeutics and Amgen, a California-based biopharmaceutical company, expand their prior relationship to a multi-year drug discovery collaboration to identify novel molecules aimed for Parkinson’s disease. These two organizations will combine their respective strengths to discover and develop novel drugs to treat Parkinson’s and other neurodegenerative diseases.